We conclude that (1) the existing evidence suggests that AD patients who drive present a slightly increased risk for crashes compared with drivers of all ages but a lower risk than young unimpaired drivers, especially males. (2) During the first 2 to 3 years after the onset of AD, the magnitude of risk of crashes is well within the accepted risk for other registered drivers. (3) There is marked variability in the degree of disability due to AD and its rate of progression. Because of this, direct tests of driving competence-rather than the diagnosis of AD per se-should be considered as the criterion for continued licensure to drive, with sufficiently frequent retesting to anticipate the expected decline over years.
Driver route-following and safety errors in early Alzheimer disease.
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OBJECTIVE: To assess navigation and safety errors during a routefollowing task in drivers with Alzheimer disease (AD). DESIGN/METHODS: Thirty-two subjects with probable AD (by National Institute of Neurological and Communicative Disorders criteria) of mild severity and 136 neurologically normal older adults were tested on a battery of visual and cognitive tests of abilities that are critical to safe automobile driving.
Each driver also performed a route-finding task administered on the road in an instrumented vehicle. Main outcome variables were number of 1) incorrect turns; 2) times lost; and 3) at-fault safety errors. RESULTS: The drivers with mild AD made significantly more incorrect turns, got lost more often, and made more at-fault safety errors than control subjects, although their basic vehicular control abilities were normal. The navigational and safety errors were predicted using scores on standardized tests sensitive to visual and cognitive decline in early AD.
CONCLUSIONS: Drivers with Alzheimer disease made more errors than neurologically normal drivers on a route-following task that placed demands on driver memory, attention, and perception. The demands of following route directions probably increased the cognitive load during driving, which might explain the higher number of safety errors. Driving and Alzheimer's disease Recommendations from the American Academy of Neurology 2000
• Explain to patients and their families that individuals with Alzheimer's disease (AD), scoring >= 1.0 on Clinical Dementia Rating (CDR) scale, have a substantially increased accident rate and driving performance errors, and that disontinuation of driving should be strongly considered.
• Explain to patients and their families that individuals with possible AD, scoring 0.5 on the CDR scale, pose a significantly greater traffic safety problem than other older drivers.
• Consider patients for referral to a qualified examiner for a driving performance evaluation.
• Reassess dementia severity and appropriateness of continued driving every six months, because of the likelihood of progression to a CDR score of 1.0 within a few years. " To determine the validity and reliability of clinician ratings of the driving competence of patients with mild dementia. DESIGN: Observational study of a cross-section of drivers with mild dementia based on chart review by clinicians with varying types of expertise and experience. SETTING: Outpatient dementia clinic. PARTICIPANTS: Fifty dementia subjects from a longitudinal study of driving and dementia. MEASUREMENTS: Each clinician reviewed information from the clinic charts and the first study visit. The clinician then rated the drivers as safe, marginal, or unsafe. A professional driving instructor compared these ratings with total driving scores on a standardized road test and categorical ratings of driving competence. Clinicians also completed a visual analog scale assessment of variables that led to their determinations of driving competence. RESULTS: Accuracy of clinician ratings ranged from 62% to 78% for the instructor's global rating of safe versus marginal or unsafe. In general, there was moderate accuracy and interrater reliability. Accuracy could have been improved in the least-accurate raters by greater attention to dementia duration and severity ratings, as well as less reliance on the history and physical examination. The most accurate predictors were clinicians specially trained in dementia assessment, who were not necessarily the most experienced in their years of clinical experience.
Conclusion: Although a clinician may be able to identify many potentially hazardous drivers, accuracy is insufficient to suggest that a clinicians assessment alone is adequate to determine driving competence in those with mild dementia. Anosognosia in Alzheimer's disease
• Present research has shown the number of AD patients suffering from anosognosia is approximately 20% (Migliorelli, Teson, and Sabe, 1995) .
• Most researchers and clinicians believe the number to be higher.
• Our research show number as high as 40%.
Why the need for an Anosognosia Instrument? Unawareness of cognitive deficit (cognitive anosognosia) in probable AD and control subjects.
Barrett AM, Eslinger PJ, Ballentine NH, Heilman KM.
Department of Neurology, Pennsylvania State University College of Medicine, Hershey, USA. abarrett@kmrrec.org OBJECTIVE: To develop a quantitative method of assessing cognitive anosognosia in six cognitive and two noncognitive domains. METHODS: Control (n = 32) and probable Alzheimer disease (pAD) (n = 14) subjects self-estimated memory, attention, generative behavior, naming, visuospatial skill, limb praxis, mood, and uncorrected vision, both before and after these abilities were assessed. Based on this estimate and their performance the authors calculated an anosognosia ratio (AR) by dividing the difference between estimated and actual performance by an estimated and actual performance sum. With perfect awareness, AR = 0. Overestimating abilities would yield a positive AR (< or =1); underestimation would yield a negative AR (> or =-1). RESULTS: Relative to controls, pAD subjects demonstrated anosognosia. Pre-testing (off-line), pAD subjects overestimated their visuospatial skill; post-testing (on-line), pAD subjects overestimated their memory. Control subjects also made self-rating errors, underestimating their attention pre-testing and overestimating limb praxis and vision post-testing.
CONCLUSIONS: This anosognosia assessment method may allow more detailed examination of distorted selfawareness. These results suggest that screening for anosognosia in probable Alzheimer's disease (pAD) should include self-estimates of visuospatial function, and memory. Driving and Alzheimer's Disease Summary
• AD (moderate,?mild) patients have an increased crash rate compared to the general elderly population.
• DOT estimates that elderly drivers will increase from 10% to 17% of the population by the year 2020.
• 50% of AD patients have a neurological condition (Anosognosia) which actually makes self appraisal of driving ability impossible.
Driving and Alzheimer's Disease Summary
• There is very little research from evidence based medicine to establish parameters for sound and just determinations of driving abilities in patients with Alzheimer's disease.
• No clear guidelines for the physician, society or the law to determine objective assessments for the balance of risks and benefits to society as well as the individual.
Driving and Alzheimer's Disease Summary
• Any solution must balance respect for the patient with concern for their safety and that of the families and society in general.
• Any solution should involve a clinically tested diagnostic system.
• Establish research from evidence based medicine by using objective assessment tools for driving skills.
Driving and Alzheimer's disease "Tips" for management 
